The TP53 and NFKB pathways remained significantly enriched in HCC tumor cells compared to cell lines when normal infiltrating cells were removed from the tumor-cell population, while the KRAS and IL6/STAT3 pathways were only significantly enriched with a less stringent statistical cutoff. This evidence concerns the gene KRAS and hepatocellular carcinoma.